Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
649.60
Change Change %
-15.25 -2.29%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
646.25
Change Change %
-18.20 -2.74%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Credit Suisse
N/A
13-01-2016 Hold 849.55 900.00
N/A
Target Hit Custom
13-01-2017

Credit Suisse upgrades Glenmark Pharmaceuticals to neutral

Expect earnings per share CAGR of 25 per cent over FY16-18. Consensus is yet to reflect the hit in Venezuela. Positive if conversion of profits to cash flows improves. Nitroglycerin launch in the fourth quarter of 2016 is a key catalyst.

Top